Physician profile
Nathan Johnston
NPI 1619232113
$435,203.12
in general payments reported to CMS, 2019-2025
13 companies · $221K in 2025
The $221K reported for 2025 was more than what 99% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $478 · 2021: $223 · 2022: $352 · 2023: $110K · 2024: $103K · 2025: $221K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $281K · Honoraria: $98K · Travel and Lodging: $45K · Food and Beverage: $9,950 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $281,097.00 |
| Honoraria | $97,625.00 |
| Travel and Lodging | $44,813.25 |
| Food and Beverage | $9,949.66 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $321,434.29 | 2019-2025 | Spravato |
| Axsome Therapeutics, INC. | $111,411.52 | 2023-2025 | Auvelity |
| Brainsway USA INC | $1,232.85 | 2020-2025 | Deep Tms |
| Allergan, INC. | $348.83 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $200.00 | 2025 | Spravato |
| Alkermes, INC. | $128.81 | 2023 | Lybalvi, Aristada |
| Abbvie INC. | $118.18 | 2021 | |
| Lundbeck LLC | $113.61 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.23 | 2020-2021 | |
| Shire North American Group INC | $61.81 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.52 | 2025 | Cobenfy |
| Avanir Pharmaceuticals, INC. | $18.83 | 2019 | |
| Bausch Health US, LLC | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.